Angels Santé

Odimma is a biotech company that focuses on precision medicine and cure for personalized cancer immunotherapy.

Healshape creates natural breast reconstruction solutions for all women. Healshape is a biotech startup focused on regenerative medicine.

Vaxxel is an Innovative viral live-attenuated platform that develops novel and proprietary live-attenuated vaccine candidates against bronchiolitis and pneumonia caused by pneumovirus.

Mapatho developed an online medical directory and search platform designed to allow patients to find free medical and pathology experts.

Gaoma Therapeutics is a biotechnology company that develops therapeutic molecules for neurological and inflammatory diseases. The company’s initial medicine candidate, GAO-3-02, is a novel proprietary active component. Gaoma Therapeutics specializes in epilepsy and cognitive diseases, but it plans to investigate the potential of its compounds in other areas as well.

OncoDiag is a French biotechnology company based in Normandy at one hour from Paris and Rouen cities. The company is focused on developing of non-invasive diagnostic tests for early detection of cancers. Its lead product the Urotest (CE-IVD) is a urine test for diagnosis and surveillance of bladder cancer. The company's pipeline also includes the Colodiag in development for early detection of colorectal cancer.

Omini develops a biosensor platform that allows the simultaneous detection of multiple biomarkers. It provides personalized blood biomarker data that can be used to adjust therapies and prevent acute crises in patients with chronic conditions.

Braintale develops and distributes accessible and effective diagnosis and prognosis tools for brain-injured patients. BrainTale’s products are based on medical needs understanding, fulfilling healthcare professionals and patients’ expectations, and is built upon more than 15 years of clinical development. The company was founded in 2018 and based in Paris, France.

SeaBeLife is a biotechnology company that develops a range of drug candidates intended to block regulated necrosis (or regulated cell death of cells), from a family of patented molecules.

Hillo is a development of tools for continuous blood glucose monitoring. The company provides services for the medical industry.

Primaa is a MedTech company offering an AI-based platform for automated and accurate cancer diagnosis. Leveraging image analysis and deep learning, our technology enhances the detection of major cancer biomarkers and guide personalized treatment.

Wefight is an open door for patients treated outside clinical settings. It makes it possible to offer services and facilitates the collect of data in real life. Our goal: to secure patients at home and save time for care teams.

OncoDiag is a French biotechnology company based in Normandy at one hour from Paris and Rouen cities. The company is focused on developing of non-invasive diagnostic tests for early detection of cancers. Its lead product the Urotest (CE-IVD) is a urine test for diagnosis and surveillance of bladder cancer. The company's pipeline also includes the Colodiag in development for early detection of colorectal cancer.

C4Diagnostics develops and commercializes IVD kits based on its proprietary, versatile, phenotypic and simple technology.

Cardiawave was created at the end of 2014 as a result of a partnership of over 6 years between the team at the Langevin Institute, a world leader in ultrasound imaging and therapy, and the team at the Georges Pompidou European Hospital (HEGP), a leader in the field of valve disease and cardiac ultrasound imaging. Led by an experienced management team, 2017 Prizewinner of Worldwide Innovation Contest 3rd phase, Cardiawave has secured over €14m since inception, to develop its product and to pursue preclinical studies before first-in-man expected in 2019.

Running Care is a class I medical device (93/42 / EEC) for the diagnosis and rehabilitation of injuries related to running. This medical device is a regulated health product which carries, under these regulations, the CE marking.

Hillo is a development of tools for continuous blood glucose monitoring. The company provides services for the medical industry.

Auxivia creates an innovative solution to prevent dehydration in dependent people. They provide connected glasses, which work exactly like normal glasses but allow for monitoring and traceability of water intake.

Cypheme is an artificial intelligence capable of detecting counterfeit products by analyzing the product's packaging with a neural network, using only a cellphone camera.

Cardiawave was created at the end of 2014 as a result of a partnership of over 6 years between the team at the Langevin Institute, a world leader in ultrasound imaging and therapy, and the team at the Georges Pompidou European Hospital (HEGP), a leader in the field of valve disease and cardiac ultrasound imaging. Led by an experienced management team, 2017 Prizewinner of Worldwide Innovation Contest 3rd phase, Cardiawave has secured over €14m since inception, to develop its product and to pursue preclinical studies before first-in-man expected in 2019.

BibeliB is a brand of smart and trendy travel accessories. They created the first smart suit case. This suitcase bag is equipped with e an integrated traceability and insurance system. Thanks to our My BibeliB Paris app your suitcase cover is now connected to geolocate your suitcase and activate it more easily.

Medicapp Connect is a simplified joint-stock company developing applications for managing healthcare data that enables healthcare professionals to create, fill, classify, and communicate patient records.